Effects of Levodopa-Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson’s Disease: INSIGHTS Study

Background. Nonmotor symptoms (NMS) are common in advanced Parkinson’s disease (APD) and reduce health-related quality of life. Objective. The aim of the study was to evaluate levodopa-carbidopa intestinal gel (LCIG) versus optimized medical treatment (OMT) on NMS in APD. Methods. INSIGHTS was a pha...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Parkinson's disease Jg. 2022; H. 1; S. 1216975
Hauptverfasser:	Chung, Sun Ju, Calopa, Matilde, Ceravolo, Maria G., Tambasco, Nicola, Antonini, Angelo, Chaudhuri, K. Ray, Robieson, Weining Z., Sánchez-Soliño, Olga, Zadikoff, Cindy, Jin, Man, Barbato, Luigi M.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Hindawi 2022 John Wiley & Sons, Inc Wiley
Schlagworte:	Carbidopa Comparative analysis Dopa Dopamine Drug dosages Dyskinesia FDA approval Health aspects Intestine Levodopa Medical research Medical treatment Medicine, Experimental Movement disorders Neurodegenerative diseases Parkinson's disease Patients Peripheral neuropathy Quality of life Sleep
ISSN:	2090-8083, 2042-0080
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!